Project 461752

Machine Learning Design of a Post-ERCP Pancreatitis Clinical Decision Tool (PEP-CADET)

461752

Machine Learning Design of a Post-ERCP Pancreatitis Clinical Decision Tool (PEP-CADET)

$577,576
Project Information
Study Type: Unclear
Research Theme: Clinical
Institution & Funding
Principal Investigator(s): Forbes, Nauzer; Heitman, Steven J
Co-Investigator(s): Barkun, Alan N; Brenner, Darren M; Causada Calo, Natalia S; Chen, Yen-I; Lix, Lisa M; Studts, Christina; Tse, Frances
Institution: University of Calgary
CIHR Institute: Nutrition, Metabolism and Diabetes
Program: Project Grant
Peer Review Committee: Clinical Investigation - C: Digestive, Endocrine and Excretory Systems
Competition Year: 2022
Term: 4 yrs 0 mth
Abstract Summary

Endoscopic retrograde cholangio-pancreatography (ERCP) is a commonly performed procedure to treat conditions of the pancreas and bile ducts. About 50 000 ERCPs are performed in Canada every year, comparable to the number of appendectomies or hip replacements. Post-ERCP pancreatitis (PEP) is the most common risk of ERCP, occurring in over 10% of patients. Over $20M of annual Canadian healthcare spending is directly related to the consequences of PEP. Several evidence-based methods exist to reduce the risk of PEP, but many are costly or impractical. A clinical decision tool that predicts PEP risk for a specific patient and gives the doctor recommendations on which PEP prevention method(s) to use could significantly improve patient outcomes and reduce healthcare spending. In this proposal, we describe the design and testing of such a tool.

No special research characteristics identified

This project does not include any of the advanced research characteristics tracked in our database.

Keywords
Clinical Decision Tool Endoscopic Retrograde Cholangiopancreatography Pancreatitis